Well, the next phase of the trial is going to be again run exclusively out of the Univeristy of Michigan -- and I believe the length of an individual person's experiment will again be something like a month... but they are going to enroll people for 3 years. So, that's "good" from the perspective of getting lots of data, bad from the perspective that the earliest they'd possibly hit market is probably 2022 or something.
I may move forward on trying to cobble together my own thing; the tech here is actually pretty simple, the difficult part is not building the device, but testing that the timing is precisely correct.
If anyone here has a background in electrical engineering or signals analysis, hit me up.
Are you sure? The information I have from Susan Shore (from around a week ago) is that the trial is going to last about one year.but they are going to enroll people for 3 years.
Well, the next phase of the trial is going to be again run exclusively out of the Univeristy of Michigan -- and I believe the length of an individual person's experiment will again be something like a month... but they are going to enroll people for 3 years. So, that's "good" from the perspective of getting lots of data, bad from the perspective that the earliest they'd possibly hit market is probably 2022 or something.
I may move forward on trying to cobble together my own thing; the tech here is actually pretty simple, the difficult part is not building the device, but testing that the timing is precisely correct.
If anyone here has a background in electrical engineering or signals analysis, hit me up.
I think if you yawn, you are able to make your tinnitus louder, I would say you have a somatic element to your tinnitus. Hence, a possible candidate for treatment using this device down the track if/when it hits the market.Hhhmmmm. I wonder if my tinnitus is modified through these indirect somatic components if I have any? I certainly can't manipulate it with basic movements or poking myself, although when I yawn it appears louder - is that a somatic component?
You mean the info I emailed you Markku?Are you sure? The information I have from Susan Shore (from around a week ago) is that the trial is going to last about one year.
No, your inquiry had been after mine.You mean the info I emailed you Markku?
Even more basically, I'd like to know what signal timing is. Is it a sound or a current and how is it enacted on the body with Susan Shore's device?Why signal timing is applicable to this particular 'type' of tinnitus?
Susan Shore As I understand, the treatment needs to be customized and delivered on a regular basis. Wondering (regular basis) as in how often. Then after trials and approval process from the FDA's (within the States) from the Center for Devices and Radiological Health ( CDRH), how long will it take for adoption per care specialists. They will have to go thru training and be certified.
If approved and marketed, will this be another treatment where one will have to travel long distances for treatment.
I'm familiar with approval processes from different agencies world wide - and I know that the USA is the slowest. I have a lot more to question, but I've been open minded for now.
Dr. Shore doesn't need to go through the FDA process to get this treatment to market because it's not a drug.
Even more basically, I'd like to know what signal timing is. Is it a sound or a current and how is it enacted on the body with Susan Shore's device?
The idea is to deliver a tactile stimulus to the jaw at a specific time interval relative to moderate sound stimulation.
Thanks for your explanation @HomeoHebbian! Do you know how they determine the timing of the stimulus? Or is it the same for everybody? I'm assuming it's some kind of mild electrical stimulation.
If I post that information I will put their placebo control at risk, potentially excluding people on this forum from participating in their trial. The timing info is public domain knowledge, if you know where to look. Sorry to be cryptic, but it might be for the best if I don't say.
Hi @HomeoHebbian - you seem to be better educated on the neurology of this than I am, and I really like and respect what you've had to say in this thread, but I'm not sure this is correct. As a participant in the first trial, this is not consistent with what I was told, so I would like to divulge all that. All the information I'm about to post here is either something I was told as a participant in the first trial (which does not exclude me from the next trial), or has been published by the University itself in a publicly available youtube video.If I post that information I will put their placebo control at risk, potentially excluding people on this forum from participating in their trial. The timing info is public domain knowledge, if you know where to look. Sorry to be cryptic, but it might be for the best if I don't say.
To clarify the study design: it is a 4 year study, combined animal and humans. The first year is animals only. Recruitment of humans begins in Year 2 and will continue to Year 4.
I spoke with [Dr. Shore] yesterday to get some clarification on when the device might be available. They are still working out a plan and nothing is confirmed yet. However, yes, there is a possibility that the device would be commercially available within a couple years (sooner than the study ends). However, they don't know for sure yet.
Hi @HomeoHebbian - you seem to be better educated on the neurology of this than I am, and I really like and respect what you've had to say in this thread, but I'm not sure this is correct. As a participant in the first trial, this is not consistent with what I was told, so I would like to divulge all that. All the information I'm about to post here is either something I was told as a participant in the first trial (which does not exclude me from the next trial), or has been published by the University itself in a publicly available youtube video.
I've had some contact with one of the clinicians there about the status of the upcoming study; I will be back to share that here once I get a confirmation from them that everything I have been told is public information.
No, it wouldn't be I was one of the subjects. Phase-I was a crossover design, so I received the real treatment and sham treatment without knowing which is which. There was essentially no difference in how it felt; the voltages being used here are low enough that you're not necessarily able to feel the zaps in a tactile way. I'm suppose I might have worked it out with a voltage meter, but didn't for obvious reasons.Their study already isn't double-blind, as you yourself said that one control group would have sound alone without tactile stimulation. Obviously, as the subject, it would be pretty easy to tell if you were in the control group, in that case!
I must agree with Eric, I have emailed Dr.Shore and I was not very impressed.
The research is still in the animal model stage and I didn`t get the impression that it was spectacular. She said IF animal tests will succeed, human trials could begin in at least one year from now.
Why would signal timing therapy be short lived? If plasticity morphed aka a bonefide shift in excited neurons creating a new plastic state inducing tinnitus...and this neural track can be damped with competing signal timing, why doesn't it have memory to change permanently?If I post that information I will put their placebo control at risk, potentially excluding people on this forum from participating in their trial. The timing info is public domain knowledge, if you know where to look. Sorry to be cryptic, but it might be for the best if I don't say.